Australia markets closed

Beijing Balance Medical Technology Co.,Ltd. (688198.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
135.50+0.05 (+0.04%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 18.50B
Enterprise value 17.99B
Trailing P/E 180.60
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)57.36
Price/book (mrq)16.81
Enterprise value/revenue 55.89
Enterprise value/EBITDA 150.16

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 320.12%
S&P500 52-week change 318.92%
52-week high 3157.38
52-week low 397.51
50-day moving average 3124.95
200-day moving average 3122.72

Share statistics

Avg vol (3-month) 3172.95k
Avg vol (10-day) 3204.85k
Shares outstanding 5136.58M
Implied shares outstanding 6136.58M
Float 835.16M
% held by insiders 173.79%
% held by institutions 19.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 40.37%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 30.37%
5-year average dividend yield 4N/A
Payout ratio 466.67%
Dividend date 3N/A
Ex-dividend date 425 May 2023
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023

Profitability

Profit margin 31.71%
Operating margin (ttm)25.88%

Management effectiveness

Return on assets (ttm)4.58%
Return on equity (ttm)9.60%

Income statement

Revenue (ttm)321.88M
Revenue per share (ttm)2.36
Quarterly revenue growth (yoy)37.10%
Gross profit (ttm)263.81M
EBITDA 90.05M
Net income avi to common (ttm)102.06M
Diluted EPS (ttm)0.75
Quarterly earnings growth (yoy)37.30%

Balance sheet

Total cash (mrq)632.75M
Total cash per share (mrq)4.66
Total debt (mrq)7.8M
Total debt/equity (mrq)0.71%
Current ratio (mrq)12.33
Book value per share (mrq)8.11

Cash flow statement

Operating cash flow (ttm)152.43M
Levered free cash flow (ttm)-38.57M